Table 1.
Baseline Characteristics and Variables
| Placebo | Prednisolone 7.5 mg | Prednisolone 30 mg | p | |
|---|---|---|---|---|
| n | 16 | 24 | 24 | |
| Age (years) | 22 ± 3 | 22 ± 2 | 22 ± 2 | 0.982 |
| Weight (kg) | 77 ± 8 | 75 ± 6 | 75 ± 8 | 0.800 |
| Height (cm) | 185 ± 6 | 184 ± 7 | 185 ± 4 | 0.659 |
| BMI (kg/m2) | 22.3 ± 1.8 | 22.3 ± 1.7 | 21.9 ± 1.8 | 0.642 |
| SBP (mm Hg) | 120 ± 9 | 124 ± 8 | 121 ± 11 | 0.461 |
| DBP (mm Hg) | 75 ± 11 | 73 ± 11 | 77 ± 12 | 0.445 |
| Sclerostin (pg/mL) | 98 [85 to 114] | 115 [91 to 132] | 108 [86 to 124] | 0.135 |
| P1NP (μg/L) | 69 [60 to 115] | 82 [60 to 103] | 72 [55 to 101] | 0.555 |
| CTx (ng/L) | 574 [422 to 758] | 606 [478 to 746] | 541 [433 to 650] | 0.557 |
Data are means ± SD or as medians [interquartile range]. Between‐group baseline differences were tested by ANOVA or by Kruskal‐Wallis test as non‐parametric test (p).
SBP = systolic blood pressure; BDP = diastolic blood pressure.